MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$257,630
Free Cash flow
$1,813,210
Unit: Dollar
Positive Cash Flow Breakdown
Deferred revenue
Net income
Provision for doubtful accounts
Others
Negative Cash Flow Breakdown
Repayment of line of credit
Accounts payable
Accounts receivable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Net income
554,586
47,108
-3,817,433
749,408
Depreciation and amortization expense
243,633
244,212
243,011
244,090
Impairment of public inventory
-
-
4,358,834
-
Impairment of investment - tianhe stock
-
-
0
0
Loss on sale of property and equipment
0
-
0
-633
Losses on marketable securities
72,019
-240,458
-201,648
-193,886
Unrealized gain on interest rate swap contract
-
-
0
0
Compensatory element of stock options
64,904
158,549
42,903
36,780
Provision for doubtful accounts
320,783
213,341
88,598
413,611
Deferred income tax benefit
-
-
-2,818,688
-
Amortization of debt issuance costs
5,109
5,136
5,165
5,192
Amortization of operating lease right-of-use asset
99,896
97,787
87,222
109,540
Accounts receivable
415,170
182,853
101,398
315,517
Prepaid expenses
113,058
-178,529
-44,712
-3,415
Inventory
-62,821
-51,803
23,540
-21,511
Other current assets
-195,159
-24,435
288,991
-47,339
Deposits and other assets, net
-79,102
112,647
7,320
30,450
Accounts payable
-454,404
430,737
258,850
370,475
Accrued expenses
79,854
-1,390,667
1,993,452
-389,123
Operating lease liability
-112,643
-109,654
-106,957
-114,728
Other liabilities
-
-
0
0
Deferred revenue
1,307,358
755,553
1,120,745
1,190,654
Net cash from operating activities
1,845,911
651,827
1,280,813
2,536,716
Purchases of property and equipment
32,701
67,065
67,226
38,788
Sale of property and equipment
0
-
0
0
Payment of duke license agreement
-
-
0
0
Proceeds from liquidation of marketable securities
-
-
0
0
Purchases of marketable securities
149,399
507,304
487,619
585,896
Sale of marketable securities
217,139
593,473
265,196
1,729,285
Net cash from (used) in investing activities
35,039
19,104
-289,649
1,104,601
Treasury stock purchases
0
-
0
80,883
Repayments of note payable
46,570
40,290
37,340
35,819
Repayment of line of credit
1,600,000
1,900,000
2,900,000
3,420,000
Proceeds from the exercise of stock options
23,250
-
0
23,101
Proceeds from line of credit
0
1,200,000
2,000,000
0
Dividends paid
0
0
0
0
Proceeds from swap termination
-
-
0
0
Net cash used in financing activities
-1,623,320
-740,290
-937,340
-3,513,601
Increase (decrease) in cash and cash equivalents
257,630
-69,359
53,824
127,716
Cash and cash equivalents - beginning of period
249,672
319,031
265,207
560,960
Cash and cash equivalents - end of period
507,302
249,672
319,031
265,207
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Deferred revenue
$1,307,358
(-36.17%↓ Y/Y)
Net income
$554,586
(-13.16%↓ Y/Y)
Sale of marketable
securities
$217,139
(-72.63%↓ Y/Y)
Provision for doubtful
accounts
$320,783
(-12.49%↓ Y/Y)
Depreciation and
amortization expense
$243,633
(-51.09%↓ Y/Y)
Other current assets
-$195,159
(-213.43%↓ Y/Y)
Amortization of operating
lease right-of-use...
$99,896
(-46.33%↓ Y/Y)
Accrued expenses
$79,854
(102.55%↑ Y/Y)
Deposits and other
assets, net
-$79,102
(-228.22%↓ Y/Y)
Compensatory element of stock
options
$64,904
(-80.76%↓ Y/Y)
Inventory
-$62,821
(-7.90%↓ Y/Y)
Amortization of debt issuance
costs
$5,109
(-51.18%↓ Y/Y)
Net cash from
operating activities
$1,845,911
(11.13%↑ Y/Y)
Net cash from (used)
in investing...
$35,039
(101.96%↑ Y/Y)
Canceled cashflow
$1,167,294
Canceled cashflow
$182,100
Increase (decrease) in
cash and cash...
$257,630
(160.84%↑ Y/Y)
Canceled cashflow
$1,623,320
Accounts payable
-$454,404
(-222.50%↓ Y/Y)
Accounts receivable
$415,170
(3862.64%↑ Y/Y)
Prepaid expenses
$113,058
(819.66%↑ Y/Y)
Operating lease liability
-$112,643
(44.52%↑ Y/Y)
Losses on marketable
securities
$72,019
(117.53%↑ Y/Y)
Proceeds from the
exercise of stock options
$23,250
Purchases of marketable
securities
$149,399
(-94.20%↓ Y/Y)
Purchases of property and
equipment
$32,701
(-73.73%↓ Y/Y)
Net cash used in
financing activities
-$1,623,320
(-451.66%↓ Y/Y)
Canceled cashflow
$23,250
Repayment of line of credit
$1,600,000
(-56.76%↓ Y/Y)
Repayments of note payable
$46,570
(-37.42%↓ Y/Y)
Buy us a coffee
CRYO CELL INTERNATIONAL INC (CCEL)
CRYO CELL INTERNATIONAL INC (CCEL)